Journal of Medicinal Chemistry · 2010 · 85 citations · 18 references
MedicineMedicinal ChemistryPharmacologyApoptosisCancer PharmacologyDrug DiscoveryApoptosis PharmacologyCell Cycle PharmacologyMitotic InhibitorsOncology PharmacologyStructure-activity Relationship AnalysisAnti-apoptotic AgentsAurora Kinase InhibitionOral Bioavailability OptimizationOral Drug BioavailabilityPharmacological ProfilingProtein Kinase InhibitorsPyrazole ChemistrySelectivity
The inhibition of Aurora kinases in order to arrest mitosis and subsequently inhibit tumor growth via apoptosis of proliferating cells has generated significant discussion within the literature. We report a novel class of Aurora kinase inhibitors based upon a phthalazinone pyrazole scaffold. The development of the phthalazinone template resulted in a potent Aurora-A selective series of compounds (typically >1000-fold selectivity over Aurora-B) that display good pharmacological profiles with significantly improved oral bioavailability compared to the well studied Aurora inhibitor VX-680.
18
A quantitative analysis of kinase inhibitor selectivity
Mazen W. Karaman, Sanna Herrgård, Daniel K. Treiber et al. · Nature Biotechnology · 2008 · 2.4K citations
Silke Hauf, Richard W. Cole, Sabrina LaTerra et al. · The Journal of Cell Biology · 2003 · 1.2K citations · Full text